420 related articles for article (PubMed ID: 12784273)
1. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
[TBL] [Abstract][Full Text] [Related]
3. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections.
Kalf JG; Smit AM; Bloem BR; Zwarts MJ; Mulleners WM; Munneke M
Parkinsonism Relat Disord; 2007 Dec; 13(8):532-4. PubMed ID: 17383926
[TBL] [Abstract][Full Text] [Related]
6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A in the treatment of sialorrhea.
Benson J; Daugherty KK
Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
9. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
10. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
[TBL] [Abstract][Full Text] [Related]
11. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
12. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
[TBL] [Abstract][Full Text] [Related]
19. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling.
Marina MB; Sani A; Hamzaini AH; Hamidon BB
J Laryngol Otol; 2008 Jun; 122(6):609-14. PubMed ID: 17640435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
